Every 8-K that Arteris, Inc. (AIP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow AIP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIP filings page.
Arteris, Inc. reported second quarter 2026 results with revenue of $24.1 million, up 46% year-over-year. Annual Contract Value (ACV) plus royalties reached $99.5 million, up 44%, variable royalties were $8.6 million, and Remaining Performance Obligation was $135 million, all described as record or new high metrics.
The company recorded a GAAP operating loss of $13.9 million and net loss of $14.1 million ($0.30 per share), while Non-GAAP net loss was $4.7 million ($0.10 per share). Free cash flow for the quarter was $8,615 (in thousands), and cash and cash equivalents were $93,270 (in thousands) as of June 30, 2026, helped by $72,546 (in thousands) of net proceeds from an at-the-market stock offering in the first half. Guidance for Q3 2026 calls for revenue of $24.0–$25.0 million, and for full-year 2026 revenue of $95.0–$98.0 million, Non-GAAP operating loss of $7.0–$10.0 million, and free cash flow of $5.0–$9.0 million.
Arteris, Inc. appointed Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. He will also serve as principal financial and accounting officer, succeeding Nick Hawkins, who is retiring after seven years and will support the transition in an advisory role.
Under a July 16, 2026 offer letter, Sinha will receive a $440,000 annual base salary and a target bonus equal to 60% of base salary. As inducement equity, he will receive performance stock units with a target value of $1,000,000, vesting only if Arteris reaches $200,000,000 in trailing four-quarter revenue by December 31, 2030 and a $65 average share price over 15 trading days by December 31, 2031, plus Restricted Stock Units valued at $3,700,000 vesting over four years. A further $1,000,000 PSU award is planned under the 2027 Long-Term Incentive Program, with share counts based on the 30-day trailing average stock price.
Arteris, Inc. held its annual stockholder meeting on June 2, 2026. Stockholders voted on electing three Class II directors and ratifying the company’s independent auditor. As of the April 9, 2026 record date, 46,092,618 shares of common stock were entitled to vote.
Antonio J. Viana, Wayne C. Cantwell, and Joachim Kunkel were each elected as Class II directors to serve until the 2029 annual meeting or until a successor is elected. Stockholders also ratified the selection of Deloitte & Touche LLP as Arteris’ independent registered public accounting firm for the fiscal year ending December 31, 2026, with 36,095,687 votes cast in favor.
Arteris, Inc. reported strong growth for the first quarter ended March 31, 2026, with revenue of $22.9 million, up 39% year-over-year. Annual Contract Value plus royalties reached $92.8 million, also up 39%, and Remaining Performance Obligation was $118.3 million, up 33%.
The company recorded a GAAP operating loss of $9.3 million, including acquisition-related costs, and a Non-GAAP operating loss of $2.5 million. GAAP net loss was $8.0 million or $0.17 per share, while Non-GAAP net loss was $1.2 million or $0.03 per share.
For Q2 2026, Arteris estimates revenue of $23.0–$24.0 million and Non-GAAP operating loss of $2.0–$3.0 million, and for full-year 2026 it guides to revenue of $91.0–$95.0 million, Non-GAAP operating loss of $4.5–$8.5 million, and positive free cash flow. The company announced that Chief Financial Officer Nicholas B. Hawkins will retire effective August 31, 2026, for family reasons and will remain as an advisor during the transition.
Arteris, Inc. reported strong growth for the fourth quarter and full year 2025 while remaining unprofitable. Q4 revenue reached $20.1 million, up 30% year over year, with Annual Contract Value plus royalties at a record $83.6 million, up 28%.
Remaining performance obligations were $116.8 million, up 32%, and Q4 non-GAAP free cash flow was positive $3.0 million. For 2025, revenue was $70.6 million, up 22%, but GAAP net loss was $34.7 million. 2026 guidance calls for revenue of $89.0–$93.0 million and non-GAAP operating loss of $5.0–$9.0 million.
Arteris, Inc. furnished a Form 8‑K stating it issued a press release with financial results for the quarter ended September 30, 2025. The press release is provided as Exhibit 99.1 and incorporated by reference.
The company noted that the information in Items 2.02 and 9.01, including Exhibit 99.1, is being furnished and not deemed “filed” under the Exchange Act. Arteris’ common stock trades on Nasdaq under the symbol AIP.